| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 286,0 k € | -16.0% | 340,3 k € | +23.7% | 275,1 k € | +15.2% | 238,9 k € | +3.5% | 230,8 k € | +26.2% | 182,8 k € | +14.7% | 159,3 k € | +17.7% | 135,4 k € | +195.4% | 45,8 k € | -59.8% | 114,0 k € | +1.1% | 112,7 k € | +2.2% | 110,3 k € | +1.0% | 109,2 k € | +15.0% | 95,0 k € | -6.1% | 101,2 k € | +21.9% | 83,0 k € | -28.7% | 116,4 k € | +84.8% | 63,0 k € | +1.9% | 61,8 k € | +16.2% | 53,2 k € | |
| EBITDA | 284,8 k € | -15.9% | 338,7 k € | +23.8% | 273,6 k € | +15.2% | 237,5 k € | +3.5% | 229,5 k € | +26.4% | 181,5 k € | +23.8% | 146,7 k € | +55.3% | 94,5 k € | +3638.6% | 2,5 k € | -96.7% | 75,4 k € | +2.6% | 73,5 k € | +1.7% | 72,3 k € | +2.0% | 70,9 k € | +24.6% | 56,9 k € | -9.4% | 62,8 k € | +43.6% | 43,7 k € | -44.7% | 79,1 k € | +172.7% | 29,0 k € | +16.1% | 25,0 k € | +5.2% | 23,8 k € | |
| Operating profit | 207,3 k € | -19.5% | 257,6 k € | +34.3% | 191,8 k € | +21.8% | 157,5 k € | +5.3% | 149,6 k € | +44.6% | 103,5 k € | +40.9% | 73,5 k € | +121.4% | 33,2 k € | +184.3% | -39,4 k € | -174.3% | 53,0 k € | -8.0% | 57,6 k € | +4.5% | 55,1 k € | +31.4% | 41,9 k € | +67.0% | 25,1 k € | -10.4% | 28,0 k € | +167.1% | 10,5 k € | -79.8% | 52,0 k € | +1761.6% | 2,8 k € | +134.1% | -8,2 k € | -28.6% | -6,4 k € | |
| Profit/loss | 144,9 k € | -15.1% | 170,8 k € | +42.5% | 119,9 k € | +27.3% | 94,2 k € | -5.0% | 99,1 k € | +47.3% | 67,3 k € | +50.1% | 44,8 k € | +257.3% | 12,5 k € | +122.7% | -55,3 k € | -267.3% | 33,0 k € | -9.3% | 36,4 k € | +7.3% | 34,0 k € | +27.9% | 26,6 k € | +54.5% | 17,2 k € | +2.9% | 16,7 k € | +57692.2% | 28,9 € | -99.9% | 46,3 k € | +1530.2% | -3,2 k € | +76.7% | -13,9 k € | -28.2% | -10,8 k € | |
| Equity | 708,3 k € | +25.7% | 563,4 k € | +43.5% | 392,6 k € | +43.9% | 272,8 k € | +28.9% | 211,6 k € | +88.1% | 112,5 k € | +148.8% | 45,2 k € | +11436.6% | 391,9 € | +103.2% | -12,2 k € | -128.2% | 43,1 k € | -46.1% | 80,0 k € | +83.6% | 43,6 k € | +353.3% | 9,6 k € | -89.7% | 93,1 k € | +22.7% | 75,9 k € | +28.2% | 59,2 k € | +0.0% | 59,1 k € | +362.2% | 12,8 k € | -20.2% | 16,0 k € | -46.4% | 29,9 k € | |
| Total assets | 1,6 M € | +3.0% | 1,5 M € | +13.2% | 1,4 M € | +7.8% | 1,3 M € | -2.2% | 1,3 M € | -3.1% | 1,3 M € | +2.9% | 1,3 M € | +13.7% | 1,1 M € | +58.5% | 722,4 k € | +379.5% | 150,6 k € | +41.8% | 106,2 k € | +6.3% | 99,9 k € | +10.5% | 90,4 k € | -35.1% | 139,2 k € | -2.8% | 143,2 k € | -0.0% | 143,3 k € | -7.4% | 154,8 k € | +33.6% | 115,9 k € | -20.4% | 145,5 k € | +7.2% | 135,7 k € | |
| Cash | 34,7 k € | -60.7% | 88,3 k € | +319.7% | 21,0 k € | +7.3% | 19,6 k € | -6.6% | 21,0 k € | +285.6% | 5,4 k € | +3204294.1% | 0,2 € | -100.0% | 108,4 k € | +20460749.1% | 0,5 € | -100.0% | 9,7 k € | -21.8% | 12,3 k € | -17.3% | 14,9 k € | +798353.5% | 1,9 € | 0.0% | 1,9 € | -23.4% | 2,4 € | -18.7% | 3,0 € | -27.7% | 4,2 € | +2084.2% | 0,2 € | -100.0% | 907,4 € | — | ||
| Debts | 878,8 k € | -10.1% | 977,0 k € | +1.0% | 967,5 k € | -2.1% | 988,1 k € | -8.3% | 1,1 M € | -11.4% | 1,2 M € | -3.0% | 1,3 M € | +9.9% | 1,1 M € | +55.4% | 734,5 k € | +583.1% | 107,5 k € | +310.5% | 26,2 k € | -53.5% | 56,3 k € | -30.3% | 80,8 k € | +75.0% | 46,2 k € | -31.5% | 67,4 k € | -19.9% | 84,1 k € | -12.0% | 95,6 k € | -7.2% | 103,1 k € | -20.4% | 129,4 k € | +22.3% | 105,8 k € | |
| Staff | — | — | — | — | — | — | — | 0,8 | 0,8 | 0,8 | 0,8 | 0,8 | 0,8 | 0,8 | 0,8 | 0,8 | 0,8 | 0,8 | 0,8 | 0,8 | ||||||||||||||||||||
Private limited company · Woluwe-Saint-Lambert · incorporated on 21/11/2003
Private limited company profitable and well capitalised. Cash position declining (-60.7%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
LAGUMED is a Private limited company incorporated in 2003. Its main activity is: Specialist medical practice activities. Its registered office is in Woluwe-Saint-Lambert.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette